Related Experiment Video
Updated: Jan 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The genetic script of metastasis
Goodwin G Jinesh1,2, Andrew S Brohl2,3
1Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, U.S.A.
Abstract:
Metastasis is a pivotal event that changes the course of cancers from benign and treatable to malignant and difficult to treat, resulting in the demise of patients. Understanding the genetic control of metastasis is thus crucial to develop efficient and sustainable targeted therapies. Here we discuss the alterations in epigenetic mechanisms, transcription, chromosomal instability, chromosome imprinting, non-coding RNAs, coding RNAs, mutant RNAs, enhancers, G-quadruplexes, and copy number variation to dissect the genetic control of metastasis. We conclude that the genetic control of metastasis is predominantly executed through epithelial to mesenchymal transition and evasion of cell death. We discuss how genetic regulatory mechanisms can be harnessed for therapeutic purposes to achieve sustainable control over cancer metastasis.
Insights
Understanding cancer metastasis is key to developing targeted therapies. Genetic factors like epigenetic changes and RNA alterations drive metastasis, primarily through epithelial to mesenchymal transition and evading cell death.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Metastasis transforms treatable cancers into malignant and fatal diseases.
- Understanding the genetic underpinnings of metastasis is critical for effective cancer therapy.
Purpose of the Study:
- To dissect the genetic control of cancer metastasis.
- To explore how genetic regulatory mechanisms can be leveraged for therapeutic interventions.
Main Methods:
- Review of alterations in epigenetic mechanisms, transcription, and chromosomal dynamics.
- Analysis of non-coding RNAs, coding RNAs, mutant RNAs, enhancers, G-quadruplexes, and copy number variations.
- Focus on epithelial to mesenchymal transition and cell death evasion.
Main Results:
- Genetic control of metastasis involves diverse mechanisms including epigenetics, transcription, and RNA alterations.
- Epithelial to mesenchymal transition and evasion of cell death are predominant pathways in metastasis.
- Copy number variations and G-quadruplexes play roles in metastasis regulation.
Conclusions:
- Genetic regulatory mechanisms are central to cancer metastasis.
- Targeting these genetic pathways offers potential for sustainable control of metastatic disease.
- Harnessing genetic insights can lead to novel and effective cancer therapies.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

